rs753248521
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PS4_SupportingPP3PP4
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1070A>G (p.Glu357Gly) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence codes (PM2, PP3, PP4 and PS4-supporting) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows:PM2 - PopMax MAF = 0.000008800 (0.00088%) in European (Non-Finnish) exomes+genomes (gnomAD v2.1.1).PP3 - REVEL = 0.984.PP4 - Variant meets PM2 and is identified in at least one case who fufills clinical criteria for FH (see PS4 for details), after alternative causes of high cholesterol were excluded.PS4_supporting - Variant meets PM2 and is identified in 4 index cases (3 cases with Simon-Broome criteria of possible FH in PMID:34456049 (Marco-Benedí et al., 2022), Spain; 1 case with internationally accepted criteria (Defesche et al, 2000) in PMID:16250003 (Fouchier et al, 2005), The Netherlands. LINK:https://erepo.genome.network/evrepo/ui/classification/CA031903/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LDLR | NM_000527.5 | c.1070A>G | p.Glu357Gly | missense_variant | Exon 8 of 18 | ENST00000558518.6 | NP_000518.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251270Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135846
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 1 Pathogenic:2Uncertain:1
The NM_000527.5(LDLR):c.1070A>G (p.Glu357Gly) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying evidence codes (PM2, PP3, PP4 and PS4-supporting) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2 - PopMax MAF = 0.000008800 (0.00088%) in European (Non-Finnish) exomes+genomes (gnomAD v2.1.1). PP3 - REVEL = 0.984. PP4 - Variant meets PM2 and is identified in at least one case who fufills clinical criteria for FH (see PS4 for details), after alternative causes of high cholesterol were excluded. PS4_supporting - Variant meets PM2 and is identified in 4 index cases (3 cases with Simon-Broome criteria of possible FH in PMID: 34456049 (Marco-Benedí et al., 2022), Spain; 1 case with internationally accepted criteria (Defesche et al, 2000) in PMID: 16250003 (Fouchier et al, 2005), The Netherlands. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at